<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="origin" name="referrer"/>
  <meta content="/images/branding/googleg/1x/googleg_standard_color_128dp.png" itemprop="image"/>
  <title>
   Is Focal, Inc. a subsidiary of another company besides Genzyme? - Google Search
  </title>
  <style>
   a{color:#1a0dab;text-decoration:none;-webkit-tap-highlight-color:rgba(0,0,0,.10)}a:visited{color:#4b11a8}a:hover{text-decoration:underline}img{border:0}html{font-family:arial,sans-serif;font-size:14px;line-height:20px;-webkit-text-size-adjust:100%;color:#3c4043;word-wrap:break-word;background-color:#fff}.bz1lBb{background-color:#fff;height:93px;}.KP7LCb{background-color:#fff;padding-left:4px}.BsXmcf{position:absolute;height:1px;left:0;right:0;background-color:#dadce0}.cOl4Id{background-color:#fff}.bRsWnc{overflow:hidden}.N6RWV{height:51px}.Uv67qb{font-size:14px;line-height:20px;font-weight:bold;display:flex}.Uv67qb a,.Uv67qb span{color:#5e5e5e;height:20px;margin:4px 12px 1px;display:block;flex:none;text-align:center;}.OXXup{border-bottom:2px solid #1f1f1f}.Uv67qb .OXXup{font-weight:bold;color:#1f1f1f}a.eZt8xd:visited{color:#5e5e5e}.FElbsf{border-left:1px solid #dadce0}header article{overflow:visible}.Pg70bf{height:39px;display:-webkit-box;display:flex;display:flex;width:100%}.H0PQec{position:relative;flex:1}.Pg70bf{height:26px}.hlm7Y{height:46px;margin-top:26px;border-radius:25px;width:auto;background:#fff;box-shadow:0px 2px 6px rgba(60,64,67,0.16)}.sbc{display:flex}.Pg70bf input{}.x{width:26px;color:#70757a;line-height:40px;margin-top:3px;font:27px/38px arial, sans-serif}#qdClwb{flex:0 0 auto;padding:0;height:33px;margin-top:5px;border-top-right-radius:25px;border-bottom-right-radius:25px;width:48px;background:#fff;border:0;border-left:1px solid #dadce0;background-image:url('data:image/svg+xml,\00003csvg height="37px" width="37px" xmlns="http://www.w3.org/2000/svg">\00003cg fill="none" stroke="%234285F4">\00003cellipse cx="16.5" cy="16" rx="5.4" ry="5.4" stroke-width="2px">\00003c/ellipse>\00003cpath d="M22 21.3l4.3 4.3" stroke-linecap="round" stroke-width="2px">\00003c/path>\00003c/g>\00003c/svg>');}.sc{font-size:16px;position:absolute;top:48px;left:0;right:0;box-shadow:0 2px 5px rgba(0,0,0,.2);z-index:2;background-color:#fff}.sc>div{padding:10px 20px}.scs{background-color:#fafafa;}.noHIxc{display:block;font-size:16px;padding:0 0 0 8px;flex:1;height:35px;outline:none;border:none;width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);overflow:hidden;padding:4px 0 0 20px}.sbc input[type=text]{background:none}html{background-color:#fff;}body{padding:0;}body{margin:0 auto 0 156px;max-width:652px;min-width:652px;padding:0 8px}.cOl4Id{text-align:center;padding:32px 28px 0 24px;position:absolute;left:0;top:0}footer{text-align:center;margin-top:18px}footer a,footer a:visited,.smiUbb{color:#70757a}.xeDNfc{margin:0 13px;display:inline-block}#EOlPnc{margin-top:36px}#EOlPnc>div{margin:20px}.Srfpq{color:#70757a}
  </style>
 </head>
 <body jsmodel="hspDDf ">
  <header id="hdr">
   <div class="cOl4Id">
    <a href="/?sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QOwgC">
     <svg aria-label="Google" fill="none" height="36" stroke="#4285f4" stroke-width="18" viewbox="0 0 520 174" width="92">
      <path d="M69 70.4l61 0m-9 3.5a56 57 0 1 1-17-47" stroke-width="19px">
      </path>
      <ellipse cx="179" cy="90" rx="33" ry="34" stroke="#ea4335">
      </ellipse>
      <ellipse cx="270" cy="90" rx="33" ry="34" stroke="#fbbc04">
      </ellipse>
      <ellipse cx="358" cy="90" rx="32" ry="34" stroke-width="17px">
      </ellipse>
      <path d="M391 49l0 73l-2 0a 22 22-30 0 1-59 24">
      </path>
      <path d="M423 5l0 130" style="stroke:#34a853">
      </path>
      <path d="M509 110a32 35-3 1 1 3-29M517 76l-63 24" stroke="#ea4335" stroke-width="16px">
      </path>
     </svg>
    </a>
   </div>
   <div class="bz1lBb">
    <form class="Pg70bf hlm7Y" id="sf">
     <input name="num" type="hidden" value="100"/>
     <input name="lr" type="hidden" value="lang_en"/>
     <input name="sca_esv" type="hidden" value="838ca97d1d112653"/>
     <input name="sca_upv" type="hidden" value="1"/>
     <input name="hl" type="hidden" value="en"/>
     <input name="gbv" type="hidden" value="1"/>
     <input name="gl" type="hidden" value="us"/>
     <input name="tbs" type="hidden" value="lr:lang_1en"/>
     <div class="H0PQec">
      <div class="sbc esbc">
       <input autocapitalize="none" autocomplete="off" class="noHIxc" name="q" spellcheck="false" type="text" value="Is Focal, Inc. a subsidiary of another company besides Genzyme?"/>
       <input name="oq" type="hidden"/>
       <input name="aqs" type="hidden"/>
       <div class="sc">
       </div>
      </div>
     </div>
     <button id="qdClwb" type="submit">
     </button>
    </form>
   </div>
  </header>
  <div id="main">
   <div>
    <div class="KP7LCb">
     <div class="bRsWnc">
      <div class="N6RWV">
       <div class="Pg70bf Uv67qb">
        <span class="OXXup">
         All
        </span>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=nws&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q_AUIBigB">
         News
        </a>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=bks&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q_AUIBygC">
         Books
        </a>
        <a class="eZt8xd" href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=isch&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q_AUICCgD">
         Images
        </a>
        <a href="/url?q=https://maps.google.com/maps%3Fhl%3Den%26q%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bof%2Banother%2Bcompany%2Bbesides%2BGenzyme%253F%26iflsig%3DAL9hbdgAAAAAZpa0f7pAwGDWsJeyVCEFOzYoOSBIPzsa%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26um%3D1%26ie%3DUTF-8%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QiaAMCAkoBA&amp;usg=AOvVaw23CsIUI0BO82X1ONP4uo6R">
         Maps
        </a>
        <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=vid&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q_AUICigF">
         Videos
        </a>
        <a href="/url?q=/search%3Fq%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bof%2Banother%2Bcompany%2Bbesides%2BGenzyme%253F%26num%3D100%26lr%3Dlang_en%26sca_esv%3D838ca97d1d112653%26sca_upv%3D1%26hl%3Den%26gbv%3D1%26gl%3Dus%26tbs%3Dlr:lang_1en%26tbm%3Dshop%26source%3Dlnms%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QiaAMCAsoBg&amp;usg=AOvVaw0hwxZP4mpOSrdZpzyUAoN4">
         Shopping
        </a>
        <div class="FElbsf">
         <a href="/advanced_search" id="st-toggle" role="button" style="white-space:nowrap">
          Search tools
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="Pg70bf wEsjbd Gx5Zad xpd EtOod pkphOe" id="st-card">
     <style>
      .wEsjbd{height:44px;white-space:nowrap}.coPU8c{height:60px;-webkit-overflow-scrolling:touch;overflow-x:auto;overflow-y:hidden}.Xj2aue{height:44px;overflow:hidden}.RnNGze{margin:11px 16px}.wEsjbd div,.wEsjbd a,.wEsjbd li{outline-width:0;outline:none}
     </style>
     <div class="Xj2aue">
      <div class="coPU8c">
       <div class="RnNGze">
        <style>
         .PA9J5{display:inline-block}.RXaOfd,.tbcPJb{display:inline-block;height:22px;position:relative;padding-top:0;padding-bottom:0;padding-right:16px;padding-left:0;line-height:22px;cursor:pointer;text-transform:uppercase;font-size:12px;color:#70757a}.sa1toc{background:#fff;display:none;position:absolute;border:1px solid #dadce0;box-shadow:0 2px 4px rgba(0,0,0,.3);margin:0;white-space:nowrap;z-index:103;line-height:17px;padding-top:5px;padding-bottom:5px;padding-left:0}.PA9J5:hover .sa1toc{display:block}.mGSy8d a:active,.RXaOfd:active{color:#4285f4}
        </style>
        <div class="PA9J5">
         <div class="RXaOfd vQYuGf" role="button" tabindex="0">
          <style>
           .TWMOUc{display:inline-block;padding-right:14px;white-space:nowrap}.vQYuGf{font-weight:bold}.OmTIzf{border-color:#909090 transparent;border-style:solid;border-width:4px 4px 0 4px;width:0;height:0;margin-left:-10px;top:50%;margin-top:-2px;position:absolute}.RXaOfd:active .OmTIzf{border-color:#4285f4 transparent}
          </style>
          <div class="TWMOUc">
           Search English pages
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <style>
           .ozatM{font-size:12px;text-transform:uppercase}.ozatM .yNFsl,.ozatM li{list-style-type:none;list-style-position:outside;list-style-image:none}.yNFsl.SkUj4c,.yNFsl a{color:#70757a;text-decoration:none;padding:6px 44px 6px 14px;line-height:17px;display:block}.SkUj4c{background-image:url(//ssl.gstatic.com/ui/v1/menu/checkmark2.png);background-position:right center;background-repeat:no-repeat}.SkUj4c:active{background-color:#f8f9fa}
          </style>
          <li class="yNFsl">
           <style>
            .tbcPJb a{color:#70757a;text-decoration:none}
           </style>
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbas=0&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIDA">
            Any language
           </a>
          </li>
          <li class="yNFsl SkUj4c">
           Search English pages
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           Any time
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           Any time
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:h&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIDw">
            Past hour
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:d&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIEA">
            Past 24 hours
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:w&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIEQ">
            Past week
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:m&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIEg">
            Past month
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:y&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIEw">
            Past year
           </a>
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           All results
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           All results
          </li>
          <li class="yNFsl">
           <a href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=li:1&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QpwUIFQ">
            Verbatim
           </a>
          </li>
         </ul>
        </div>
        <div class="tbcPJb" role="button" tabindex="0">
         <a href="https://www.google.com/search?hl=en&amp;source=hp&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;btnG=Google+Search&amp;iflsig=AL9hbdgAAAAAZpa0f7pAwGDWsJeyVCEFOzYoOSBIPzsa&amp;gbv=1&amp;gl=us&amp;num=100">
          Clear
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div class="BsXmcf">
   </div>
   <style>
    .Gx5Zad{margin-bottom:30px;margin:0px 0px 8px;}.pkphOe{font-size:14px;line-height:22px;}.EtOod>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.EtOod.avPKgf>*:last-child{border-bottom-left-radius:4px}.EtOod>.qxDOhb>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>.qxDOhb>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.fP1Qef{background:transparent !important;box-shadow:none !important;border:none !important}.rl7ilb{display:block;clear:both}.egMi0{margin-bottom:-23px}.kCrYT{padding:16px 14px 12px}a.fdYsqf{color:#4b11a8}.sCuL3{position:absolute;width:100%;top:0;left:0;padding-top:1px;margin-bottom:-1px}.j039Wc{padding-top:28px;margin-bottom:-1px}.DnJfK{position:relative}.l97dzf{font-weight:400}.zBAuLc{line-height:normal;margin:0;padding:0}.BNeawe{white-space:pre-line;word-wrap:break-word}.vvjwJb{color:#1a0dab;font-size:20px;line-height:26px}a:visited .vvjwJb,.vvjwJb a:visited{color:#4b11a8}.vvjwJb.HrGdeb{color:#fff}a:visited .vvjwJb.HrGdeb,.vvjwJb.HrGdeb a:visited{color:rgba(255,255,255,.70)}.UwRFLe{display:-webkit-box;-webkit-box-orient:vertical;overflow:hidden}.UPmit{font-size:14px;line-height:22px}.UPmit.HrGdeb{color:rgba(255,255,255,.70)}.UPmit.AP7Wnd{color:#202124}.lRVwie{text-overflow:ellipsis;white-space:nowrap;overflow:hidden}.Ap5OSd{padding-bottom:12px}.s3v9rd{font-size:14px;line-height:22px}.s3v9rd.HrGdeb{color:#fff}.s3v9rd.AP7Wnd{color:#202124}.mSx1Ee{padding-left:48px;margin:0}.v9i61e{padding-bottom:8px}.U8ml0d{text-decoration:line-through}.XLloXe{color:#1a0dab;font-size:14px;line-height:20px}a:visited .XLloXe,.XLloXe a:visited{color:#4b11a8}.XLloXe.HrGdeb{color:#fff}a:visited .XLloXe.HrGdeb,.XLloXe.HrGdeb a:visited{color:rgba(255,255,255,.70)}.K8tyEc{padding-bottom:12px}.mEUgP{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;height:14px;padding:16px 14px 0px 14px;margin:0}.FCUp0c{font-weight:bold}.nRlVm .FCUp0c{background-color:#d3e3fd;color:#040c28}.C7GS5b{margin-left:12px;display:table-cell;vertical-align:middle}.rkGIWe{padding:14px}.rxk4ae{padding-top:6px;padding-bottom:6px}.yStFkb .xpd{box-shadow:none;border-radius:16px;background-color:#f7f8f9;}.oTWEpb{padding-top:16px}.n1Qedd{overflow:hidden;text-align:center}.KMAGC{margin:0 auto;display:block}.ho0sdc{margin:0 -50%;display:inline-block}.PqksIc{font-size:16px;line-height:20px}.x54gtf{height:1px;background-color:#dadce0;margin:0 14px}.Q0HXG{height:1px;background-color:#dadce0;}.Xb5VRe{color:#1a0dab}a:visited .Xb5VRe{color:#4b11a8}.Xb5VRe.tr0dw{color:#fff}a:visited .Xb5VRe.tr0dw{color:rgba(255,255,255,.70)}.P1NWSe{display:table;width:100%;padding-top:16px;padding-bottom:16px;margin-bottom:-12px}.wOMIed{display:table-cell;vertical-align:top}.nkPlDb{vertical-align:middle}.JhFlyf{color:#3c4043;font-size:14px;text-align:center}.VQFmSd{display:block;white-space:pre-line;word-wrap:break-word}.JhFlyf.VQFmSd{line-height:22px}.f4J0H{padding:18px}.r0bn4c.tr0dw{color:rgba(255,255,255,.70)}.r0bn4c.rQMQod{color:#70757a}.iIWm4b{box-sizing:border-box;min-height:48px}.gGQDvd{position:relative;padding:20px 14px 14px 14px;height:60px;}.Q71vJc{display:block;position:relative;width:100%}.kjGX2{position:absolute;vertical-align:bottom;display:inline-block;right:48px;left:0;color:#4d5156;}.Xe4YD{font-size:16px}.ieB2Dd{overflow:hidden;margin-top:-10px;margin-bottom:-16px;margin-right:8px;border-radius:4px;display:inline-block;border-radius:50%;padding:8px 7px 8px 9px;background-color:#f7f8f9;}.toMBf{position:absolute;right:0;margin-right:-8px;margin-top:-2px}.d9dqO{flex:none}.z1asCe{display:inline-block;fill:currentColor;height:24px;line-height:24px;position:relative;width:24px}.z1asCe svg{display:block;height:100%;width:100%}.C5GhQc{color:rgba(0,0,0,.54);}.rLshyf,.BmP5tf{padding-top:16px;padding-bottom:12px}.YOx3Ab{padding-left:14px;}.w1C3Le,.BmP5tf,.G5NbBd,.CS4w5b{padding-left:14px;padding-right:14px;}.G5NbBd{padding-bottom:12px}.CS4w5b{padding-top:12px}.nMymef{display:flex}.G5eFlf{flex:1;display:block}.nMymef span{text-align:center}.EYqSq{margin:6px 4px 9px 0;border-radius:100%;display:inline-block;height:10px;vertical-align:middle;width:10px}.dfB0uf{color:#3c4043;font-weight:bold}.IffyKc{word-wrap:break-word}
   </style>
   <div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGUQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/732485/000091205702012898/a2073695z10-k.htm&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGUQAg&amp;usg=AOvVaw2AlerkTcM5x_8LIzF7NTQq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           genzyme corporation - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Wirth has responsibility for Genzyme's corporate development and legal activities, Genzyme Molecular Oncology and our GelTex Pharmaceuticals subsidiary.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIZRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIZRAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="K8tyEc">
      <div class="mEUgP">
       <span>
        <div class="BNeawe">
         <span class="FCUp0c rQMQod">
          People also ask
         </span>
        </div>
       </span>
      </div>
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        What company owns Genzyme?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div class="Ap5OSd">
             <div class="BNeawe">
              <span class="FCUp0c rQMQod">
               Sanofi
              </span>
             </div>
            </div>
            <div>
             <div class="BNeawe">
              Genzyme was an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) has been a fully owned subsidiary of
              <span class="FCUp0c rQMQod">
               Sanofi
              </span>
              .
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAAQBg" href="/url?q=https://en.wikipedia.org/wiki/Genzyme&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAAQBg&amp;usg=AOvVaw3wTwuehNV3gIyEji86jnqr">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Genzyme - Wikipedia
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             en.wikipedia.org › wiki › Genzyme
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qzmd6BAgAEAc" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=cKaWZpCGKqG7vr0Pqsm88AE&amp;q=What+company+owns+Genzyme?&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qzmd6BAgAEAc">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        Where is Sanofi Genzyme?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              The Company¹s headquarters are located in
              <span class="FCUp0c rQMQod">
               Cambridge, Massachusetts, USA
              </span>
              .
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAAQDQ" href="/url?q=https://www.massbio.org/members/sanofi-genzyme/&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAAQDQ&amp;usg=AOvVaw2q4Xsf-lYz6oA1v-2nYWUC">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Sanofi Genzyme - MassBio
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             www.massbio.org › members › sanofi-genzyme
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qzmd6BAgAEA4" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=cKaWZpCGKqG7vr0Pqsm88AE&amp;q=Where+is+Sanofi+Genzyme?&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qzmd6BAgAEA4">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGQQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/732485/000091205702016059/a2076578zdef14a.htm&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGQQAg&amp;usg=AOvVaw2jIoRnr8mWhskLGu0yfs11">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           schedule 14a information - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           establishing Genzyme Biosurgery as a new division of the company through the ... three strategic acquisitions: Wyntek Diagnostics, Inc., Focal, Inc.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIZBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIZBAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGMQAg" href="/url?q=https://investors.ocutx.com/node/8276/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGMQAg&amp;usg=AOvVaw3zi5u7Lu0Y8mOi34Rfo0ue">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Ocular Therapeutix, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.ocutx.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal, Inc., a biopharmaceutical company subsequently acquired by Genzyme Corporation. ... affiliated with the company or any of its subsidiaries or affiliates.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYxAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYxAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGIQAg" href="/url?q=https://ir.voyagertherapeutics.com/node/8451/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGIQAg&amp;usg=AOvVaw2Yrt3MdtIoqdWCLVEUnU7c">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Voyager Therapeutics Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.voyagertherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Voyager Therapeutics, Inc. 75 Sidney Street. Cambridge, MA 02139. NOTICE OF 2019 ANNUAL MEETING OF STOCKHOLDERS. Notice is hereby given that the 2019 Annual ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYhAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGEQAg" href="/url?q=https://synapse.patsnap.com/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGEQAg&amp;usg=AOvVaw2wCBtSb8xdzl11gK7oTlE3">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse.patsnap.com › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           The company is committed to discovering and advancing new therapies to provide hope to patients and their families worldwide. Genzyme became a part of Sanofi in ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYRAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGAQAg" href="/url?q=https://investors.vcel.com/static-files/0319757e-09b1-44b8-b852-32bf1a60fa3f&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECGAQAg&amp;usg=AOvVaw0vpgBkNYKnJRQh0RMCMPsi">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Aastrom Biosciences, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... business were obtained via acquisitions by Genzyme. The acquisition of Biosurface Technologies Corporation in 1994 brought both Carticel and Epicel to Genzyme ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIYBAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF8QAg" href="/url?q=https://www.sciencedirect.com/science/article/am/pii/S0048733321000214&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF8QAg&amp;usg=AOvVaw0wiDVuC5pTjKHHsHhrDpUS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Matching patents to compustat firms, 1980–2015 - ScienceDirect.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sciencedirect.com › science › article › pii
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 7, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Abstract. This paper describes the methodology used to construct a new sample of patents matched to Compustat firms for the period 1980-2015 ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXxAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXxAG">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF4QAg" href="/url?q=https://www.encyclopedia.com/books/politics-and-business-magazines/millennium-pharmaceuticals-inc&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF4QAg&amp;usg=AOvVaw2IfxbAj7rxiZlZ32VeSCM8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Millennium Pharmaceuticals, Inc. | Encyclopedia.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.encyclopedia.com › books › politics-and-business-magazines › mille...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Millennium Pharmaceuticals, Inc. is a Cambridge, Massachusetts biotech company dedicated to the discovery and development of new drugs through the application ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXhAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFwQAg" href="/url?q=http://getfilings.com/o0000912057-00-014941.html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFwQAg&amp;usg=AOvVaw2O31p9i3zgyS1Q6tPSfIme">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/1999 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           wholly-owned subsidiary, Genzyme, B.V., and became a corporate Vice President and President of our therapeutics business unit in December 1993. From ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF0QAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340106/&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECF0QAg&amp;usg=AOvVaw1xXaupVEpfpTnyAeQYDkmE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Imiglucerase in the treatment of Gaucher disease: a history and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC3340106
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 18, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The Genzyme Corporation is now a wholly owned subsidiary of Sanofi SA. Sanofi SA is headquartered in Paris: it has activities in cardiovascular ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXRAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIXRAG">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFsQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2013-01-01-form-20-f-2013-en.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFsQAg&amp;usg=AOvVaw13NmNa0kwjwI87oJzisYe_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 20-F 2013 | Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2013-01-01-form-20-f-2013-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWxAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWxAG">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFoQAg" href="/url?q=https://synapse-patsnap-com.libproxy1.nus.edu.sg/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFoQAg&amp;usg=AOvVaw2q2_g_eCymHfegUw2RUsLg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse-patsnap-com.libproxy1.nus.edu.sg › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           The company is committed to discovering and advancing new therapies to provide hope to patients and their families worldwide. Genzyme became a part of Sanofi in ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWhAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFkQAg" href="/url?q=https://papers.ssrn.com/sol3/Delivery.cfm/UVA-F-1660.pdf%3Fabstractid%3D2974482%26mirid%3D1&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFkQAg&amp;usg=AOvVaw32t8Nt2aYAeeOnc6zQuXtl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Genzyme and Relational Investors: Science and Business Collide?
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          papers.ssrn.com › sol3 › Delivery.cfm › UVA-F-1660
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           purchased a small company, Whatman Biochemicals Ltd., which was absorbed into Genzyme. ... Biogen Idec, another major biotechnology company.19. In Termeer's ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIWRAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFcQAg" href="/url?q=https://ir.biohaven.com/node/10256/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFcQAg&amp;usg=AOvVaw07gl6XxH7Oms9obvEvyKQB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Biohaven, Ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal Epilepsy and Bipolar Disorder in second half of 2023. Biohaven ... companies affiliated with Suvretta, Social Capital Suvretta Holdings Corp. I ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFgQAg" href="/url?q=http://getfilings.com/o0000912057-01-506403.html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFgQAg&amp;usg=AOvVaw0RWVDY1lGTH5XSx_PPnRmk">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/2000 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           registered trademark of GelTex Pharmaceuticals, Inc. ... Biosurgery Corporation. Welchol-TM- is a trademark of Sankyo Pharma, Inc. NeuroCell-TM--PD is a trademark ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFYQAg" href="/url?q=https://investors.vcel.com/static-files/2eafb240-812b-403c-9fc2-9e589e0017e6&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFYQAg&amp;usg=AOvVaw3bc7A3uGw3nwx1-PjlkeKB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Investor Relations - Vericel Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 14, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... any other right or remedy of GENZYME which may have accrued up ... Genzyme Raw Materials other than the 3t3 cells outlined in Exhibit 1 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFMQAg" href="/url?q=https://ir.travere.com/node/7896/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFMQAg&amp;usg=AOvVaw2NRPdP8_R6WgS4zkWyIdnr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing ID 0001193805-13-001119 - Travere Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.travere.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary and the principal operating subsidiary of the Company. The ... Genzyme Corporation, a biotechnology company, where Dr. Plotkin led his team ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIUxAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIUxAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFQQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2015-01-01-form-20-f-2015-en.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFQQAg&amp;usg=AOvVaw3yQCokDKkWdzobPZQHpIrU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Forms 20-F 2015 - Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2015-01-01-form-20-f-2015-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 1, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIVBAG" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIVBAG">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFUQAg" href="/url?q=https://www.hrsa.gov/sites/default/files/hrsa/opa/orphan-drug-list-october-1-december-31-2022.xlsx&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFUQAg&amp;usg=AOvVaw3mm1XEN7HWVKSqKzw3EZVE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Orphan Drug List Governing January 1 to March 31, 2019 - HRSA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hrsa.gov › opa › orphan-drug-list-october-1-december-31-2022
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Treatment of pulmonary tuberculosis. Otsuka Pharmaceutical Company, Ltd ... GB002, Inc., a wholly-owned subsidiary of Gossamer Bio, Inc. 152, 151, (S)-3 ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIVRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIVRAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFEQAg" href="/url?q=https://investors.bellerophon.com/node/7366/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFEQAg&amp;usg=AOvVaw0zWrzHOmlYM-NyQtHSU8zW">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investors | Bellerophon Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.bellerophon.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... parent company, Ikaria, Inc. (a subsidiary of Mallinckrodt plc), or Ikaria. As ... In addition to any other rights available to the Holder, if the Company ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFIQAg" href="/url?q=https://ir.biohaven.com/node/9841/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFIQAg&amp;usg=AOvVaw0Wasz__krQI7-GaGQBUmOZ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Biohaven, Ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           This information statement is being furnished in connection with the distribution (the “Distribution”) by Biohaven Pharmaceutical Holding Company Ltd. (“ ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFAQAg" href="/url?q=https://ir.voyagertherapeutics.com/static-files/b3d77c06-221b-4598-b0cf-470bedfa1793&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECFAQAg&amp;usg=AOvVaw037kc4xML3KDKrzRFKtdMw">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.voyagertherapeutics.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           collaboration with Genzyme Corporation, a Sanofi company, or Genzyme, to. 2 ... from 1991 to 1992, Focal, Inc. from 1992 to 1993, and StemCells, Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE8QAg" href="/url?q=https://investor.verastem.com/static-files/0299a0a1-d665-40ca-a50a-e730337eeb58&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE8QAg&amp;usg=AOvVaw2jjSVfOAT956szUlj1N5vu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Download DOC - Investor Overview | Verastem, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.verastem.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... new information, future events or otherwise, except as required by law. 3 ... companies, including Forma Therapeutics, Inc., CombinatoRx, Inc. and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE0QAg" href="/url?q=https://c-path.org/about/people/&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE0QAg&amp;usg=AOvVaw1LGkWTbZLXf1AzxRvH9vWZ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Leaders &amp; Board of Directors - Meet Critical Path Institute Team
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          c-path.org › about › people
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           C-Path is proud to attract top talent from across the world. Meet our team, our leaders and see our board of directors today. Get to know us.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE4QAg" href="/url?q=https://www.fda.gov/medical-devices/hde-approvals/listing-cdrh-humanitarian-device-exemptions&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECE4QAg&amp;usg=AOvVaw2G9J-tq0kCzPgZqQ0ctUTg">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Listing of CDRH Humanitarian Device Exemptions | FDA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fda.gov › medical-devices › hde-approvals › listing-cdrh-humanitaria...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           Second Sight Medical Products, Inc. This epiretinal prosthesis is surgically ... DePuy Orthopaedics, Inc., a Johnson &amp; Johnson Company, This device is ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIThAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQIThAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEsQAg" href="/url?q=https://hbr.org/2006/10/can-science-be-a-business-lessons-from-biotech&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEsQAg&amp;usg=AOvVaw0iza56qdGdOf3mCduqvEz_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Can Science Be a Business?: Lessons from Biotech
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          hbr.org › 2006/10 › can-science-be-a-business-lessons-from-biotech
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           According to data from the National Venture Capital Association on fund investment policies, the average investment in a biotech firm is about $3 million. The ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEwQAg" href="/url?q=https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/Hip_GroinMTG2021.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEwQAg&amp;usg=AOvVaw1jIriRWplrP5pecoaBICn5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Hip and Groin Disorders - Workers' Compensation Board
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.wcb.ny.gov › content › main › hcpp › Hip_GroinMTG2021
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 2, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Lev Ginsburg, Esq. Senior Director of Government Affairs. The Business Council of New ... Inc. Marian Arbesman, PhD, OTR/L. Jeff Snodgrass ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEkQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/s/NYSE_SNY_2012.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEkQAg&amp;usg=AOvVaw0SjsqOx3UYdsLJvtY49qrL">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Annual Report on Form 20-F 2012 - AnnualReports.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › AnnualReportArchive › NYSE_SNY_2012
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 25, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ... Inc.; BiTE a trademark of Micromet Inc., Copaxone a trademark of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEoQAg" href="/url?q=https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/DMT_Consensus_MS_Coalition.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEoQAg&amp;usg=AOvVaw3y6mQvwuFw2GeBtvvyBJ3n">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] DMT_Consensus_MS_Coalition.pdf - National MS Society
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nationalmssociety.org › media › MSNationalFiles › Brochures
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 30, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Genzyme Corporation; Grant support: Biogen, Novartis Pharmaceuticals. ... Benign multiple sclerosis: a new definition of this entity is needed.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            company
           </span>
           <span class="U8ml0d rQMQod">
            besides
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEcQAg" href="/url?q=https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2012-GN-Guideline-English.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEcQAg&amp;usg=AOvVaw0M1N-XUzVr-chfe8psZBD_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] KDIGO Clinical Practice Guideline for Glomerulonephritis
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          kdigo.org › uploads › 2017/02 › KDIGO-2012-GN-Guideline-English
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Belo Foundation, Coca-Cola Company, Dole Food Company, Genzyme, Hoffmann-LaRoche, JC Penney, NATCO—The ... especially when the diagnostic lesions are focal and/or.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEgQAg" href="/url?q=https://assets.aeaweb.org/asset-server/files/13979.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEgQAg&amp;usg=AOvVaw0N65L4nTjxpU2EGpabEALt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Online Appendix for “Knowledge spillovers and corporate ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          assets.aeaweb.org › asset-server › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary, Monsanto Company (New Monsanto). In ... 121742) and GENZYME BIOSURGERY (GVKEY 143176) are all accounted under their parent company GENZYME CORP.
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            besides
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQISBAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Is+Focal,+Inc.+a+subsidiary+of+another+company+%22besides%22+Genzyme?&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5t4CegQISBAF">
             <span class="XLloXe AP7Wnd">
              besides
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEUQAg" href="/url?q=http://ir.scpharma.com/node/6641/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEUQAg&amp;usg=AOvVaw1Wosqmk3UEQnVrXcbaoUpU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | scPharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.scpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Ceesay served at Genzyme/Sanofi, a biotechnology company, initially ... except any such merger or consolidation involving the Corporation or a subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEYQAg" href="/url?q=https://www.neurology.org/doi/10.1212/WNL.0000000000004313&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEYQAg&amp;usg=AOvVaw2YtFirnhUSfJi8axk9fVCz">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Alemtuzumab CARE-MS I 5-year follow-up - Neurology.org
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.neurology.org › doi › WNL.0000000000004313
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 12, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           1. Yes, I own stocks of Sanofi (parent company of Genzyme), linked with my employment at Sanofi. I own these stocks since 2016. Stock/stock ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEQQAg" href="/url?q=https://www.cambridgema.gov/~/media/Files/budgetdepartment/citybondsale/Cambridge%2520PRELIM_2%252013%252013_1.ashx&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEQQAg&amp;usg=AOvVaw0Zu_tBXlZWBXTVKwK1CYFR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UBS Financial Services Inc. - the City of Cambridge
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cambridgema.gov › Files › budgetdepartment › citybondsale
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 15, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... any other governmental entity (except regional school districts, the Massachusetts Water Resources Authority and certain districts for which ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEMQAg" href="/url?q=https://www.macomptroller.org/wp-content/uploads/acfr_fy-2008.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEMQAg&amp;usg=AOvVaw0u8rA_6hdUC6kkpksHEjLj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Commonwealth of Massachusetts Comprehensive Annual Financial ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.macomptroller.org › wp-content › uploads › acfr_fy-2008
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Commonwealth may give, loan or pledge its credit to another entity by a two- ... profit subsidiary, the Worcester Foundation for Biomedical Research, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEIQAg" href="/url?q=https://www.cms.gov/files/document/open-payments-fy-2022-report-congress.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEIQAg&amp;usg=AOvVaw1jfYoVIXatzL4agJdXRnyo">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Fiscal Year 2022 Annual Report on the Open Payments Program
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cms.gov › files › document › open-payments-fy-2022-report-co...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           submitted by applicable manufacturers and GPOs. 4 When a program year reaches its fifth full year of data publication it is no longer eligible for new data ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEEQAg" href="/url?q=https://www.kireports.org/article/S2468-0249(20)30003-6/pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEEQAg&amp;usg=AOvVaw0GltW3IojGdM2V7HpdTFUP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Study Design of the Phase 3 Sparsentan Versus Irbesartan ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kireports.org › article › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 8, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... focal segmental glomer- ulosclerosis; irbesartan; proteinuria; sparsentan. © 2020 International Society of Nephrology. Published by Elsevier Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD8QAg" href="/url?q=https://www.msard-journal.com/article/S2211-0348(15)00106-6/pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD8QAg&amp;usg=AOvVaw2nr51VbOaUG8--A1-8gXRP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Optimizing therapy early in multiple sclerosis
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.msard-journal.com › article › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           another injectable (Jokubaitis et al., 2014; He et al., 2015). In the ... Genzyme Corporation, Oct 2014. AUBAGIO Prescribing Information. Available at ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD4QAg" href="/url?q=https://ir.aerovatetx.com/static-files/299c62b1-192e-4502-b9aa-0253d75b353c&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD4QAg&amp;usg=AOvVaw24HQYUjI_c1g0ubqt-uXL-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] 0001104659-21-084790.rtf - Aerovate Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.aerovatetx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold stock. We are ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEAQAg" href="/url?q=https://ir.exelixis.com/static-files/21cddf02-e799-43f7-ba64-227bb1dddfe2&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECEAQAg&amp;usg=AOvVaw2SmupFCQLNDrBRf_SJhftu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 10-K for Exelixis INC filed 02/06/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.exelixis.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 27, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Company's product sales included, among others ... relying on any promise or representa on by the Company or an affiliate of the Company that is ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD0QAg" href="/url?q=https://investor.bluebirdbio.com/static-files/600b5870-ec4b-4bc6-aaa5-cf967d10a115&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECD0QAg&amp;usg=AOvVaw3CCvpjDu_Czqot4pBXUwiR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] bluebird bio, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bluebirdbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Companies such as GlaxoSmithKline plc, Sanofi/Genzyme Corporation and ... of a public pharmaceutical company and chairman of another pharmaceutical company ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDwQAg" href="/url?q=https://ir.teknova.com/static-files/c0df6f2c-d1fc-4cc8-924c-28880c9d0adf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDwQAg&amp;usg=AOvVaw2adwI8fuo1h_IM-EV1f5Yo">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Alpha Teknova INC filed 04/29/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.teknova.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 29, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           individual, group, or another company is a “controlled company ... otherwise occur, except for a liquidation into a parent corporation;.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDsQAg" href="/url?q=https://investors.artivion.com/static-files/4a3bff84-22f2-4107-945f-989c824c17b9&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDsQAg&amp;usg=AOvVaw0_BacbGA6_U7a4h3s05rUb">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [RTF] 0000914062-01-500169.rtf - Investor Overview
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.artivion.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Person (other than the Company, any Subsidiary of the Company, any employee ... wholly owned subsidiary or Company's parent corporation to make sales of.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDkQAg" href="/url?q=https://investors.ascendispharma.com/static-files/76fa5ef4-190d-43bc-8bf4-eb794a629e7a&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDkQAg&amp;usg=AOvVaw10vT31nqGZiIL2WvNOQent">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Ascendis Pharma A/S
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.ascendispharma.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ... Inc.) has received regulatory approval of once-weekly somatrogon (brand ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDgQAg" href="/url?q=https://investors.medicinova.com/node/12096/ixbrl-viewer&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDgQAg&amp;usg=AOvVaw1XTDCXz5wftCHd1ghasBef">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           0001564590-21-006771 | 10-K | iXBRL Viewer - MediciNova, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.medicinova.com › node › ixbrl-viewer
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... companies seeking to reference another company's NDA. The FDCA provides a ... Company or its subsidiaries. The 2013 Plan is the successor to the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDoQAg" href="/url?q=https://www.ccny.cuny.edu/sites/default/files/engineering/upload/Grove-Annual-Report-2005-2006.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDoQAg&amp;usg=AOvVaw25yh5tSU5YH9gQ2ySISCfu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] grove school - of engineering - The City College of New York
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ccny.cuny.edu › upload › Grove-Annual-Report-2005-2006
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           DMJM Harris' parent company. Ms. Chmielinski has served as a member of ... Industry presenters from Genzyme Corp, Boston. Scientific, Gilead Sciences ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDYQAg" href="/url?q=https://investors.tenayatherapeutics.com/node/6351/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDYQAg&amp;usg=AOvVaw3EZC8jJRpv5-bZvsILABPu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Tenaya Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.tenayatherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We are a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDcQAg" href="/url?q=https://investors.biogen.com/static-files/76edcab0-0179-40ab-8232-aee2484c2d26&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDcQAg&amp;usg=AOvVaw1bJKxhUS9QqzikI5mgaiqZ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Form 10-K - Biogen | Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           BIOGEN INC. (Exact name of registrant as specified ... business day of the registrant's most recently completed second fiscal quarter was $58,267,511,287.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDUQAg" href="/url?q=https://ir.mallinckrodt.com/static-files/b243f547-5502-46f6-a745-81bd18cd8ec6&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDUQAg&amp;usg=AOvVaw2sJ0TLfM9Fg8bfpP2ae_MC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Questcor Pharmaceuticals, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.mallinckrodt.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Real Property or any other assets of the Company or any of the Subsidiaries. ... There are no entities other than the Company and the Subsidiaries participating ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDQQAg" href="/url?q=https://www.cirm.ca.gov/wp-content/uploads/archive/files/press_release/Top_50_Global_Stem_Cell_Influencers.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDQQAg&amp;usg=AOvVaw3QVIL7bM4mV0E5bmGKrhc5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Top 50 most influential people on Stem Cells today
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cirm.ca.gov › files › Top_50_Global_Stem_Cell_Influencers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Manager at Genzyme, a Sanofi company, ... Arnold Caplan, has been Chief Scientific. Officer of OrthoCyte Corporation, a subsidiary of BioTime, Inc., since June ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDMQAg" href="/url?q=https://scilexholding.gcs-web.com/static-files/d3a43572-5aa7-41ba-a4b4-6f0bd52e67e8&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDMQAg&amp;usg=AOvVaw261lA5jUC3lJ9N-xUJHRFx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Form S-1/A for Scilex Holding Co filed 05/23/2023
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          scilexholding.gcs-web.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... corporation that is now our wholly owned subsidiary, named Scilex, Inc. (formerly known as Scilex Holding. Company). References to “this offering” refer to ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDIQAg" href="/url?q=http://www.msac.gov.au/internet/msac/publishing.nsf/Content/E72BFBEC5447F91FCA25801000123B6D/%24File/1140_Report_Final040211.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDIQAg&amp;usg=AOvVaw0DiISEbjWLBCN4vyITq_BA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Matrix-induced autologous chondrocyte implantation and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.msac.gov.au › msac › Content › 1140_Report_Final040211
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ACI is also a viable treatment for cartilage defects in joints other than the knee, including the hip, shoulder, elbow and talus; however, based on the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDEQAg" href="/url?q=https://www.gibsondunn.com/2015-year-end-fda-and-health-care-compliance-and-enforcement-update-drugs-and-devices/&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDEQAg&amp;usg=AOvVaw2JZViOwAX_DzbAolRSLT5B">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2015 Year-End FDA and Health Care Compliance and Enforcement ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gibsondunn.com › 2015-year-end-fda-and-health-care-compliance-a...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 19, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... another company.[37] According to the government's ... In September 2015, Genzyme Corporation, a wholly owned biotechnology subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDAQAg" href="/url?q=https://www.wcb.ny.gov/content/main/hcpp/MedicalTreatmentGuidelines/TraumaticBrainInjuryMTG2021.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECDAQAg&amp;usg=AOvVaw3faZf2XzTPbx7o4sXjz5pS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Traumatic Brain Injury - NYC - Workers' Compensation Board
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.wcb.ny.gov › main › hcpp › MedicalTreatmentGuidelines › Tra...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 2, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Director, Center for Human Resources. The Business Council of New York State, Inc. ... is focal in nature and would benefit from a targeted.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC8QAg" href="/url?q=https://investors.praxismedicines.com/static-files/4665af89-afc8-4fb7-90bb-b9a98b983bfc&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC8QAg&amp;usg=AOvVaw287GhbgaJG6bkUw766F95e">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Praxis Precision Medicines INC filed 04/28/2023
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.praxismedicines.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           affiliated with the company or any of its subsidiaries or affiliates. ... in support of director nominees other than the Company's nominees ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC4QAg" href="/url?q=https://investors.atyrpharma.com/node/6736/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC4QAg&amp;usg=AOvVaw2k-jhbrI4APjSLf8YZ5kh8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | aTyr Pharma
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.atyrpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           In addition to certain members of our management team being relatively new to our company ... company, and Medivation, Inc., a biopharmaceutical company.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC0QAg" href="/url?q=https://investor.arbutusbio.com/node/14821/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECC0QAg&amp;usg=AOvVaw3WHli7xE_sdqYlNBQiFwGr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Arbutus Biopharma Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.arbutusbio.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           In addition to revocation in any other manner permitted by law ... company other than the directors or executive officers of the Company or a subsidiary.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCwQAg" href="/url?q=https://ir.biolinerx.com/static-files/bc494bca-d27a-4515-9bd5-0c09ec77b5b8&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCwQAg&amp;usg=AOvVaw27l4SkTOrVtoC4KAPspJRQ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] BioLineRx Ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biolinerx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 6, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company, and its U.S. subsidiary, Agalimmune Inc. Agalimmune Inc ... parent or subsidiary or another affiliate of such successor.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCoQAg" href="/url?q=https://orbit.dtu.dk/files/197454014/1_s2.0_S1053811919307748_main.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCoQAg&amp;usg=AOvVaw1cBCfo_Er-LSvIYRm93uBp">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Accessibility of cortical regions to focal TES - DTU Orbit
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          orbit.dtu.dk › files › 1_s2.0_S1053811919307748_main.pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND ... In addition to characterizing features and performance of the new.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCsQAg" href="/url?q=https://investors.cerevel.com/node/7626/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCsQAg&amp;usg=AOvVaw3Jww6fEkzqV9ACqRfYj_Ph">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Pfizer license agreement - SEC Filing | Cerevel Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.cerevel.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           On October 27, 2020, Cerevel Therapeutics, Inc., a private company and our ... subsidiary of ARYA and ARYA was renamed Cerevel Therapeutics Holdings, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCgQAg" href="/url?q=https://www.bayer.com/sites/default/files/2020-05/ar-2016.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCgQAg&amp;usg=AOvVaw2FbcY2yFKeGTENjPW5jy_t">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Annual Report - Bayer
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bayer.com › sites › default › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... new constellation at the start of last year, for its commit- ment to the company. Creating an integrated organizational structure and appointing the heads ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCkQAg" href="/url?q=https://www.aetna.com/cpb/medical/data/200_299/0247.html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCkQAg&amp;usg=AOvVaw3_8xhpmH3C0D0yULbm9Gci">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Autologous Chondrocyte Implantation - Medical Clinical ... - Aetna
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.aetna.com › cpb › medical › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Autologous chondrocyte implants (autologous chondrocyte transplant) (Carticel, Genzyme Inc., Cambridge, MA) has been investigated as a means of a ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCcQAg" href="/url?q=https://ir.fulcrumtx.com/node/7001/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCcQAg&amp;usg=AOvVaw3EZvu2imudZrwEnWAe3c5V">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investor Relations - Fulcrum Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.fulcrumtx.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCYQAg" href="/url?q=https://www.sechistorical.org/collection/papers/1990/1992_0101_NASDNTM-17.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCYQAg&amp;usg=AOvVaw2i0TE2LBdktqu7rWRkc51k">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] NASD - SEC Historical Society
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sechistorical.org › papers › 1992_0101_NASDNTM-17
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 21, 1992
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Genzyme Corporation (12/31/96 Wts). 8/4/92. 1000. PEAK. Peak ... fected sales of the stock of its parent company to discretionary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCUQAg" href="/url?q=https://www.congress.gov/116/chrg/CHRG-116shrg37143/CHRG-116shrg37143.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCUQAg&amp;usg=AOvVaw0OlTX9XsWvJvDPlJ1AZWbH">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] drug pricing in america: a prescription for change, part ii hearing
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.congress.gov › chrg
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 26, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Company, New York, NY ... Inc., Kenilworth, NJ .................................................................................. 12.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCQQAg" href="/url?q=https://www.finance.senate.gov/imo/media/doc/37143.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCQQAg&amp;usg=AOvVaw3g8LFVEX7DV4EnbICeOX4A">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] DRUG PRICING IN AMERICA: A PRESCRIPTION FOR CHANGE ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.finance.senate.gov › imo › media › doc
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           (III). C O N T E N T S. OPENING STATEMENTS. Page. Grassley, Hon. Chuck, a U.S. Senator from Iowa, chairman, Committee on. Finance .
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCIQAg" href="/url?q=https://ir.united.com/node/13176/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCIQAg&amp;usg=AOvVaw1HxiKmMGwDcf2F-kVBEmV5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           View HTML - SEC Filing - United Airlines Holdings, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.united.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... another loan after twelve months from the date the old loan is retired ... - The Boston Company Asset Mgt., Inc. S &amp; P 500 Index Fund, - PanAgora Asset ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCEQAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966579/&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCEQAg&amp;usg=AOvVaw1hE2YXrwYuifC1WiFBNGuS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Development and characterization of human monoclonal antibodies ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC4966579
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Another strategy utilized biotinylated TGFβ, which was captured out of ... US: Optein, Inc., Wilmington, DE (US); Genzyme Corporation, Cambridge, MA ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB8QAg" href="/url?q=https://materials.proxyvote.com/Approved/74006W/20230417/NPS_539473.PDF&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB8QAg&amp;usg=AOvVaw0JzehI3sAOtZguZzzOxVxK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] PRAX - 2023 DEF14A - A Service From Broadridge
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          materials.proxyvote.com › Approved › NPS_539473
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc., a publicly traded specialty pharmaceutical company, from 2006 until its acquisition by King Pharmaceuticals, Inc. in 2008, and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB0QAg" href="/url?q=https://www.lokvani.com/lokvani/article.php%3Farticle_id%3D8785&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB0QAg&amp;usg=AOvVaw2BaGSizy93OEqDFO-pM0gz">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Lokvani Talks To Amar Sawhney
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.lokvani.com › lokvani › article
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 13, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Confluent was acquired by Covidien. Before Confluent, Dr. Sawhney was the technology founder of Focal, Inc. (acquired by Genzyme). Dr. Sawhneyâ€ ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCMQAg" href="/url?q=https://www.auriniapharma.com/investors-and-media/sec-filings/all-sec-filings/content/0001157523-20-000260/0001157523-20-000260.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCMQAg&amp;usg=AOvVaw265DomTBhri-cc6qiX_sty">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 6-K - Aurinia Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.auriniapharma.com › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 25, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           VICTORIA, British Columbia--(BUSINESS WIRE)--February 25, 2020--Aurinia Pharmaceuticals Inc. ... another company will not create a substantial.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBwQAg" href="/url?q=https://valneva.com/wp-content/uploads/2019/06/Registration_Document_2017.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBwQAg&amp;usg=AOvVaw2HzqYIe_LW_1lfuLduR9mD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Registration Document - Valneva
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          valneva.com › wp-content › uploads › 2019/06 › Registration_Docu...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           + consider selling assets or even merging with another company. ... subsidiary of the Company, by an investment fund managed by Pharmakon ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB4QAg" href="/url?q=https://www.cms.gov/files/document/open-payments-2020-annual-report-congress.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECB4QAg&amp;usg=AOvVaw2xAKDiXU75eUjCUb6Iu1zu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Open Payments Annual Report to Congress Fiscal Year 2020 - CMS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cms.gov › files › document › open-payments-2020-annual-repo...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal Therapeutics, Inc. $85,684.58. $2,475.00. $0.00. $0.00. 488. 3. 0. 0 ... Jacobus Pharmaceutical Company, Inc. $0.00. $107,540.00. $0.00. $0.00. 0. 3. 0. 0.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCAQAg" href="/url?q=http://www.ca6.uscourts.gov/opinions.pdf/07a0073p-06.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECCAQAg&amp;usg=AOvVaw2nQDn5DnYmZE_Mk-jEeFI8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 07a0073p.06 - UNITED STATES COURT OF APPEALS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ca6.uscourts.gov › opinions.pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 22, 2007
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Lawyers Title Insurance Company (a subsidiary of LandAmerica Financial Group, Inc.), ... Genzyme Corp., 170 F. App'x 375, 378 (6th Cir ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBsQAg" href="/url?q=https://www.pieris.com/investors/sec-filings/all-sec-filings/content/0001583648-19-000011/0001583648-19-000011.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBsQAg&amp;usg=AOvVaw1bhQQECQGK9luz0j92TIdl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 0001583648-19-000011.pdf - Pieris Pharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pieris.com › investors › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBoQAg" href="/url?q=https://ir.ocugen.com/node/6596/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBoQAg&amp;usg=AOvVaw3G9rAaDJInlsRu3NQnPD_m">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Ocugen, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.ocugen.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The underwriters expect to deliver the shares against payment in New York, New York on December 8, 2014. Cowen and Company, Needham ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBkQAg" href="/url?q=http://ndl.ethernet.edu.et/bitstream/123456789/87807/5/Strategic%2520Management%2520of%2520Technological%2520Innovation%252C%2520Fourth%2520Edition%2520%2528%2520PDFDrive.com%2520%2529.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBkQAg&amp;usg=AOvVaw1INYhDIuaZNdWDpq4O5l6-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Strategic Management of Technological Innovation, Fourth Edition
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ndl.ethernet.edu.et › bitstream
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Melissa Schilling is a professor of management and organizations at New York. University's Stern School of Business. Professor Schilling teaches courses in.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBgQAg" href="/url?q=https://www.neurocrine.com/wp-content/uploads/2021/12/2019_Annual_Report.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBgQAg&amp;usg=AOvVaw18UoWgz8JsFEgw7WNRN9B9">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 2019 Annual Report | Neurocrine Biosciences
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.neurocrine.com › wp-content › uploads › 2021/12 › 2019_Ann...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Company or an Affiliate, or (C) any other form of ... Company shall otherwise occur, except for a liquidation into a parent corporation;.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBYQAg" href="/url?q=https://www.hcplive.com/view/articles_pfn_feb2008&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBYQAg&amp;usg=AOvVaw3VKKyK9RdswYMsR4PPxjrX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Physicians' Financial News: February 2008 - HCPLive
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hcplive.com › view › articles_pfn_feb2008
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 23, 2010
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Genzyme's Thyrogen Captures New Thyroid Cancer-Related Indication. Genzyme Corporation announced FDA approval for a supplemental indication ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBQQAg" href="/url?q=https://investor.bluebirdbio.com/static-files/e394b8b4-481e-4e58-baf6-b1c368721165&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBQQAg&amp;usg=AOvVaw3m1qWM6299ziEnNG06O0sK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] bluebird bio, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bluebirdbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Companies such as GlaxoSmithKline plc, Sanofi/Genzyme Corporation and ... M.I.T., or any other entity other than the PATENT RIGHTS and TANGIBLE PROPERTY.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBIQAg" href="/url?q=https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBIQAg&amp;usg=AOvVaw1wWOcj7cW7y4cnK4xI8fG2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] KDIGO 2012 Clinical Practice Guideline for the Evaluation and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          kdigo.org › uploads › 2017/02 › KDIGO_2012_CKD_GL
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Company, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa ... focal or crescentic proliferative GN; focal and segmental ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBcQAg" href="/url?q=https://biopharmguy.com/links/company-by-name-defunct.php&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBcQAg&amp;usg=AOvVaw2FVMhrQ-EsNvo97c0pBc0u">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           List of bankrupt, sold, merged, or otherwise defunct biotech, pharma ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          biopharmguy.com › links › company-by-name-defunct
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           List of defunct, bankrupt, bought, merged biotech companies.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBUQAg" href="/url?q=https://www.gao.gov/assets/a236205.html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBUQAg&amp;usg=AOvVaw1y1JEv5UrRTk9i1f0kfGI0">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           FDA Oversight of Direct-to-Consumer Advertising Has Limitations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gao.gov › assets
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Drug: Cerezyme; Condition: Gaucher disease; Company: Genzyme; Date: 7/ 13 ... Prevention Magazine, and its parent company, Rodale, Inc., have conducted ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBMQAg" href="/url?q=https://www.kaken.co.jp/english/invest/library/pdf/annual_report/cr_2018.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBMQAg&amp;usg=AOvVaw3Epg8oDeiZfc2z4ECNeXvk">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] CORPORATE REPORT 2018
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kaken.co.jp › english › invest › library › pdf › annual_report
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 1, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Ltd., a subsidiary of Mitsubishi Tanabe Pharma. Corporation, in 2017; Tai Tien Pharmaceuticals gained marketing approval from Taiwan FDA in.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBEQAg" href="/url?q=https://profoundmedical.com/wp-content/uploads/2020/03/Profound-2019-Annual-Information-Form-FINAL.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBEQAg&amp;usg=AOvVaw2RCLRM6tTIOwOpthkd6AOx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Profound Medical CORP. ANNUAL INFORMATION FORM FOR THE ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          profoundmedical.com › wp-content › uploads › 2020/03 › Profound-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 3, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           directors and employees of the Company and its subsidiaries and others as it may see fit ... of employees engaged in such function other than the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBAQAg" href="/url?q=https://meridian.allenpress.com/ijmsc/article-pdf/17/S1/1/2090224/1537-2073-17_s1_1.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECBAQAg&amp;usg=AOvVaw17Eym0vVf40hrnqq5WhTIc">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2015 2015 Annual Meeting of the CMSC - Allen Press
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          meridian.allenpress.com › ijmsc › article-pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 29, 2015
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           LEMTRADA and Genzyme are registered trademarks of Genzyme Corporation. ©2015 Genzyme Corporation, a Sanofi company. All rights reserved ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA0QAg" href="/url?q=https://www.bcbsla.com/-/media/Medical%2520Policies/2020/08/03/17/33/AutologousChondrocyteImplantationforFocalArticularCartilageLesions.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA0QAg&amp;usg=AOvVaw3Ydh_zvPAZG1IZGbazA00S">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Autologous Chondrocyte Implantation for Focal Articular Cartilage ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bcbsla.com › media › 2020/08/03 › AutologousChondrocyteIm...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 3, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAoQAg" href="/url?q=https://www.kireports.org/article/S2468-0249(20)30003-6/fulltext&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAoQAg&amp;usg=AOvVaw0ieZ-Ir79nzZW5E_gCp4QB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Study Design of the Phase 3 Sparsentan Versus Irbesartan ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kireports.org › article › fulltext
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 8, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Genzyme and Optherion. He is an unpaid consultant to Retrophin, Inc., and has an agreement with Goldfinch Biopharma through New York University.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAwQAg" href="/url?q=https://www.jstor.org/stable/3875292&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAwQAg&amp;usg=AOvVaw2LfYNPELK7DDFh23goclW4">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Technology Sourcing through Acquisitions: Evidence from the US ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.jstor.org › stable
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 18, 2004
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           the parent firm, and the value of the po union is greater than ... Genzyme Corp. Consolidated. 1997 Titan Pharmaceuticals Inc. discovery ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAsQAg" href="/url?q=https://www.drugdiscoverynews.com/bristol-myers-squibb-to-acquire-inhibitex-for-2-5-billion-5723&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAsQAg&amp;usg=AOvVaw0G5QrGn3_7KI_Lt75DCwyO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Bristol-Myers Squibb to acquire Inhibitex for $2.5 billion
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.drugdiscoverynews.com › bristol-myers-squibb-to-acquire-inhibitex-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... company worth more than $500 million, according to data compiledby Bloomberg since 1999. The record is currently held by Genzyme Corp. for its2006 deal for ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAkQAg" href="/url?q=https://casetext.com/case/in-re-pharmaceutical-industry-avg-whsle-pr&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAkQAg&amp;usg=AOvVaw1igXsTNR9Ka5xa7H_HOEyp">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           In re Pharmaceutical Industry Average Wholesale Price Litigation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          casetext.com › Browse cases › 1st Cir. › D. MA › 2007 › June
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Edwin Baum Proskauer, Rose Law Firm, New York, NY, for Warrick Pharmaceuticals Corporation (Consolidated Defendant), Biovail Pharmaceuticals, Inc. (Consolidated ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA8QAg" href="/url?q=https://investors.tenayatherapeutics.com/node/6306/html&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA8QAg&amp;usg=AOvVaw3Uh-4r0l01hEAU7o_SZ8ZS">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Tenaya Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.tenayatherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We intend to submit an investigational new drug application (IND) or a clinical trial application (CTA) to the U.S. Food and Drug Administration (FDA) or ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA4QAg" href="/url?q=https://www.nber.org/system/files/working_papers/w23187/w23187.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECA4QAg&amp;usg=AOvVaw00cp_zszIKnvmK_KtPOb2K">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Back to Basics: Why do Firms Invest in Research?
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nber.org › system › files › working_papers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 6, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           companies in the NBER database, we merge BOEING CAPITAL CORP under BOEING CO as it is a wholly owned subsidiary of the company. We adjust ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAYQAg" href="/url?q=https://www.ftc.gov/system/files/documents/cases/592986-complaint_counsels_corrected_post-trial_brief.pdf&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAYQAg&amp;usg=AOvVaw2ACHu944BOP6_b4o8dYYSr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Otto Bock HealthCare North America, Inc., In the Matter of
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ftc.gov › 592986-complaint_counsels_corrected_post-trial_brief
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 20, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company, corroborate Complaint Counsel's market shares. Even the ... Another important reason Otto Bock decided to acquire Freedom was ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAQQAg" href="/url?q=https://ir.teknova.com/static-files/b6aaf661-6385-4695-953a-eb5e6fd0322e&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAQQAg&amp;usg=AOvVaw1thCDPfH4yqjNUyUzONBpy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Alpha Teknova, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.teknova.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We are an “emerging growth company” and a “smaller reporting company,” each ... another party has filed a U.S. patent application on inventions similar ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAgQAg" href="/url?q=https://onlinelibrary.wiley.com/doi/10.1002/sej.1129&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAgQAg&amp;usg=AOvVaw33KN7vDZBg80sl5B67zwG2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Amphibious entrepreneurs and the emergence of organizational forms
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          onlinelibrary.wiley.com › doi › sej
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 7, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           That this formula was replicable is evidenced by the presence of two companies with the same founder: Genex and Cytogen, the first and second ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAUQAg" href="/url?q=https://content.edgar-online.com/ExternalLink/EDGAR/0001193125-24-055961.html%3Fhash%3D5f741d930a82791cc41ee32f722b5ac756a32a48a9c4ed377f5498e4ca3b927e%26dest%3Dd518298dex1019_htm&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAUQAg&amp;usg=AOvVaw3y4QimOXjQXL7itbbuxhPx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Spyre Therapeutics, Inc. (Form: S-1/A, Received - EDGAR Online
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          content.edgar-online.com › ExternalLink › EDGAR
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Albers was at Genzyme Corporation, a biotechnology company that is now ... Spyre merged with an into a second wholly subsidiary of the Company (“Merger ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAMQAg" href="/url?q=https://ir.travere.com/static-files/c114281c-6c1e-4ad4-b72e-3667291333b2&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAMQAg&amp;usg=AOvVaw1FfDHEYLqPNAwHRMSDj3FA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] https://ir.travere.com/static-files/c114281c-6c1e-...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.travere.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... another matter is properly brought before the meeting? The Board of ... Inc., and Bristol Laboratories, a biopharmaceutical company. Mr. Aselage ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAcQAg" href="/url?q=https://www.bioworld.com/content/biotechbig-pharma-collaborations-7&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAcQAg&amp;usg=AOvVaw06GuS5QPU1G7avYrGmsmRR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Biopharma collaborations in 2011 - | BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › content › biotechbig-pharma-collaborations-7
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Access Pharmaceuticals Inc. Undisclosed major pharmaceutical company, Deal to exploit its CobaCyte and CobOral technologies for the targeted delivery of RNAi ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAIQAg" href="/url?q=https://www.sciencedirect.com/science/article/pii/S1096719215300500&amp;sa=U&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QFnoECAIQAg&amp;usg=AOvVaw1VWvM-6Ct8GacZZU5KtMRf">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Recommendations for the use of eliglustat in the treatment of adults ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sciencedirect.com › science › article › pii
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Eliglustat (Cerdelga, Genzyme, a Sanofi company, Cambridge, MA, USA) is a ceramide analog that potently and specifically inhibits glucosylceramide synthase, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="K8tyEc">
      <div class="mEUgP">
       <span>
        <div class="BNeawe">
         People also search for
        </div>
       </span>
      </div>
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAI" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Dextenza&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAI">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Dextenza
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAQ" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Ocular+Therapeutix+stock&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAQ">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Ocular Therapeutix stock
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAY" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+Ocular+Therapeutics&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAY">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           What is Ocular Therapeutics
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAg" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=ELUTYX&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAg">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           ELUTYX
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAo" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Dextenza+cataract+surgery&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAo">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Dextenza cataract surgery
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAw" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Dextenza+removal&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEAw">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           Dextenza removal
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEA4" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=What+is+Dextenza+used+for&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEA4">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           What is Dextenza used for
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <div class="gGQDvd iIWm4b">
       <a class="Q71vJc" data-ved="2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEBA" href="/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=PAXTRAVA&amp;sa=X&amp;ved=2ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q1QJ6BAgBEBA">
        <accordion-entry-search-icon class="toMBf">
         <span class="d9dqO ieB2Dd C5GhQc z1asCe MZy1Rb" style="height:20px;line-height:20px;width:20px">
          <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
           <path d="M15.5 14h-.79l-.28-.27A6.471 6.471 0 0 0 16 9.5 6.5 6.5 0 1 0 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z">
           </path>
          </svg>
         </span>
        </accordion-entry-search-icon>
        <div class="kjGX2">
         <span class="Xe4YD">
          <div class="BNeawe lRVwie">
           PAXTRAVA
          </div>
         </span>
        </div>
       </a>
      </div>
     </div>
    </div>
   </div>
   <footer>
    <div>
     <div class="Gx5Zad xpd EtOod pkphOe BmP5tf">
      <div class="nMymef Va3FIb lVm3ye">
       <a aria-label="Next page" class="nBDE1b G5eFlf" href="/search?q=Is+Focal,+Inc.+a+subsidiary+of+another+company+besides+Genzyme%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=cKaWZpCGKqG7vr0Pqsm88AE&amp;start=100&amp;sa=N">
        Next &gt;
       </a>
      </div>
     </div>
    </div>
    <div id="EOlPnc">
     <div class="Srfpq">
      <div>
       <span class="EYqSq unknown_loc">
       </span>
       <span class="dfB0uf">
        Unknown
       </span>
      </div>
      <span>
       Can't determine location
      </span>
      <span>
       -
      </span>
      <a aria-label="Learn more about this location" class="IffyKc" href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qty4IkQQ&amp;usg=AOvVaw3Yn7cNA_zXKmkNScwhkMWX" tabindex="0">
       Learn more
      </a>
     </div>
     <div>
      <a href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fhl%253Den%2526source%253Dhp%2526q%253DIs%252BFocal,%252BInc.%252Ba%252Bsubsidiary%252Bof%252Banother%252Bcompany%252Bbesides%252BGenzyme%25253F%2526btnG%253DGoogle%252BSearch%2526iflsig%253DAL9hbdgAAAAAZpa0f7pAwGDWsJeyVCEFOzYoOSBIPzsa%2526gbv%253D1%2526lr%253Dlang_en%2526gl%253Dus%2526num%253D100%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Qxs8CCJIE&amp;usg=AOvVaw0NylCW405UGRJsnReTkCRR">
       Sign in
      </a>
     </div>
     <div>
      <a class="xeDNfc" href="https://www.google.com/preferences?hl=en&amp;fg=1&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4Q5fUCCJME">
       Settings
      </a>
      <a class="xeDNfc" href="https://policies.google.com/privacy?hl=en&amp;fg=1">
       Privacy
      </a>
      <a class="xeDNfc" href="https://policies.google.com/terms?hl=en&amp;fg=1">
       Terms
      </a>
      <a class="xeDNfc" href="/setprefs?hl=en&amp;prev=https://www.google.com/search?hl%3Den%26source%3Dhp%26q%3DIs%2BFocal,%2BInc.%2Ba%2Bsubsidiary%2Bof%2Banother%2Bcompany%2Bbesides%2BGenzyme?%26btnG%3DGoogle%2BSearch%26iflsig%3DAL9hbdgAAAAAZpa0f7pAwGDWsJeyVCEFOzYoOSBIPzsa%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26pccc%3D1&amp;sig=0_Gsfy_kUVOPzl8C8jTW-6utvg9pM%3D&amp;cs=2&amp;sa=X&amp;ved=0ahUKEwiQ_rPpg6yHAxWhna8BHaokDx4QjcAJCJQE">
       Dark theme: Off
      </a>
     </div>
    </div>
   </footer>
  </div>
  <!-- cctlcm 5 cctlcm -->
  <textarea class="csi" name="csi" style="display:none"></textarea>
 </body>
</html>
